High Throughput Gene to Antibody Production to screen MORE
Featured Product ADVERTISEMENT Feb 20, 2020
High throughput (HTP) gene to antibody production provides the most cost effective option for small-scale recombinant antibodies. This popular service combines GenScript's expertise in high-throughput gene synthesis with a proprietary transient antibody expression technology to produce high quality recombinant antibodies for both therapeutic antibody drug candidates and reagent antibodies.
Examples of antibody sequences accepted: variable region sequenced from hybridoma, hits (Fab or scFv) selected from display library based method, sequences from single B cell and/or repertoire analysis via next generation sequencing (NGS), and many more.
You provide us the sequences of the fragments and we take care of the rest. Deliverables can be supernatant or purified antibodies. There is no additional set-up fee, and the cost of gene synthesis is waived.
Fast Delivery: 13-18 BD from gene synthesis to delivery (standard package)
Flexible Options: Fabs, scFv, VHH, or other fragments fused with Fc
Cost Effective: One-stop solution with an Economy option available